Identification | Back Directory | [Name]
3,4-Dihydro-2H-benzo[1,4]oxazine-7-carboxylic acid methyl ester | [CAS]
142166-01-6 | [Synonyms]
Methyl 3,4-dihydro-2H-benzo[1,4]oxazine-7-carboxylate methyl 3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate 3,4-Dihydro-2H-benzo[1,4]oxazine-7-carboxylic acid methyl ester methyl methyl 3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate 2H-1,4-Benzoxazine-7-carboxylic acid, 3,4-dihydro-, methyl ester 3,4-Dihydro-7-(methoxycarbonyl)-2H-1,4-benzoxazine, 3,4-Dihydro-7-(methoxycarbonyl)-2H-benzo[b][1,4]oxazine | [Molecular Formula]
C10H11NO3 | [MDL Number]
MFCD11848180 | [MOL File]
142166-01-6.mol | [Molecular Weight]
193.2 |
Chemical Properties | Back Directory | [Melting point ]
86~88℃ | [Boiling point ]
337.2±41.0 °C(Predicted) | [density ]
1.198±0.06 g/cm3(Predicted) | [storage temp. ]
Keep in dark place,Sealed in dry,Room Temperature | [pka]
2.00±0.20(Predicted) | [Appearance]
Off-white to brown Solid |
Hazard Information | Back Directory | [Synthesis]
Methyl 3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-carboxylate (1 g, 4.83 mmol) was used as starting material and mixed with boron trifluoride ethyl ether complex (1.273 mL, 10.14 mmol) in tetrahydrofuran (20 mL). The reaction mixture was stirred at 0 °C for 20 min. Subsequently, sodium borohydride (0.383 g, 10.14 mmol) was slowly added to the reaction system and stirring was continued at 0 °C for 1 h. The reaction was then brought to room temperature overnight. Upon completion of the reaction, ethyl acetate (~1 mL) was added to dilute the reaction, which was subsequently quenched by the addition of 1N aqueous hydrochloric acid. Extraction was carried out with ethyl acetate at room temperature, and the organic layer was separated, washed with saturated brine, dried over anhydrous sodium sulfate, and finally concentrated under reduced pressure to afford the target product, methyl 3,4-dihydro-2H-1,4-benzoxazine-7-carboxylate (0.916 g, 4.74 mmol, 98% yield), as a light yellow solid. | [References]
[1] Patent: WO2018/30550, 2018, A1. Location in patent: Paragraph 0658 [2] Bioorganic and Medicinal Chemistry, 2006, vol. 14, # 24, p. 8219 - 8248 |
|
Company Name: |
Shangchem Co., Ltd.
|
Tel: |
+86-21-68182121 |
Website: |
www.yuhua99.com/ShowSupplierProductsList14031/0_EN.htm |
Company Name: |
Tetranov Biopharm
|
Tel: |
13526569071 |
Website: |
http://www.leadmedpharm.com/index.html |
|